Home |  About BSI My BiosynthesisServices New ProductsDistributors | SpecialsGizmo |  Tech LoungeTestimonials Forum |  Contact Us Login
     
     
Bio-Synthesis Inc. Announces Exclusive Collaboration in the Area of Immune Agonists and Antagonists 
Bio-Synthesis Unveils Free Online Software ‘Peptide, Oligo, Protein Analysis’ Click on Gizmo 
All Highlights   All Events
 
  Enter Keyword  
   
 
Advance Search
 
     
   
   
   
   
   
   
 
 
To provide you with quality peptide product for the results you can trust...
 
 

Multiple Antigen Peptide (MAP)

BIO-SYNTHESIS offers MAPS as an another method for producing high titer anti-peptide antibodies.  This newer concept was introduced to avoid chemically undefined entity of an antigen-carrier system.  The MAP system utilizes a peptidyl core of three or seven radially branched lysine core to form a backbone for which the antigen sequences of interest can be built parallel using standard solid-phase chemistry.  The heptalysien core yields the MAP bearing four or eight copies of the peptide epitope with a resulting three dimensional molecule which has a high molar ratio of peptide antigen to core molecule, and therefore, does not requere the use of a carrier protein to induce an antibody response.  These high molar ratio and dense packing of multiple copies of the antigenic epitope in a MAP has been shown to product strong immunogenic response1.2
 

For details on Multiple Antigen Peptide (MAPS), call 800-227-0627 or write to us at biosyn@biosyn.com.

 
Service Features:
Synthesis up to 10 residues

Immunization of 2 rabbits

ELISA testing on all bleeds
100-150 mls of crude serum
10-12 weeks delivery
QC peptide by HPLC and mass spectrometry
5 mgs MAP delivered to customer
 
For price quote, click here!
 
 
Standard Peptide

 
BIO-SYNTHESIS has been supplying custom peptides to customers worldwide, since our inception in 1984.
 
 
Modification
 
Our unique capabilities in synthesis of modified peptides have earned us an excellent reputation in life science research communities.
 
 
Peptide Arrays
 
Using state-of-the-art proprietary peptide synthesis platforms, Bio-Synthesis has developed